WP7: ALM - Access to Innovative Technologies

 

Access to Innovative Technologies - ALM will provide access to “beyond state of the art” imaging technologies, which are not easily accessible to the broader imaging community. This limitation is attributable to their novelty, to their still being under development, or due to the complexity of the infrastructure needed for their efficient operation. In addition, the equipment needed for such activities is not commercially available or simply too expensive for individual institutions.
 
Among the innovative imaging technologies that will be developed in the framework of this WG, we include
 
  • super resolution microscopy
  • functional imaging
  • correlative light/electron microscopy
  • high throughput- high definition microscopy for systems biology.
 
The innovative “Functional Imaging” technologies in WP7 cover advanced techniques to image biological function in cells, particularly cell signalling processes. This includes quantitative techniques such as FLIM, FRET, FCS etc, implemented at a level that is not commercially available and/or requiring a critical mass of instrumentation and expertise not easily accessible to the broader imaging community.
 
The goals of WP7 are:
 
  • to search for additional innovative light microscopy technology developments, which may be considered for inclusion in the forward planning of Euro-BioImaging infrastructure.
  • to define the needs of the scientific community with regard to instrument developments and access to the identified innovative technologies.
  • to search for existing European infrastructure enabling innovative light microscopy technologies.
  • to determine the bottlenecks for providing access to innovative light microscopy technologies.
  • to explore the feasibility of providing access to the identified innovative technologies.
  • to develop a plan for the implementation of European access to innovative technologies.
 
Work Package Chairs
 
Benjamin Geiger (Weizmann Institute of Science, Israel)
 
 
Rainer Pepperkok (European Molecular Biology Laboratory, Heidelberg, Germany)